Clinical Trials Directory

Trials / Sponsors / Shi Ming

Shi Ming

Academic / Other · 8 registered clinical trials.

StatusTrialPhaseStarted
UnknownCandonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T
Hepatocellular Carcinoma
Phase 22023-02-27
WithdrawnCandonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T
Hepatocellular Carcinoma
Phase 22022-12-07
UnknownHAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC
Intrahepatic Cholangiocarcinoma
Phase 32021-07-09
WithdrawnLenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus Infec
Hepatocellular Carcinoma
Phase 2 / Phase 32019-10-30
CompletedHAIC Plus Lenvatinib and Toripalimab for Advanced HCC
Hepatocellular Carcinoma
Phase 22019-08-01
SuspendedLenvatinib Plus PD-1 Antibody for Unresectable ICC
Intrahepatic Cholangiocarcinoma
Phase 22018-12-17
WithdrawnLenvatinib Plus PD-1 Antibody for Intermediate-stage HCC Beyond Up-to-seven Criteria
Hepatocellular Carcinoma
Phase 22018-12-01
UnknownHAIC Versus Systemic Chemotherapy for Unresectable ICC
Intrahepatic Cholangiocarcinoma
Phase 32018-08-01